Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 50 entries
Sorted by: Best Match Show Resources per page
New data base program for quality control of strabismus surgery.

Strabismus

Stärk N, Stärk P, Zubcov AA.
PMID: 21314507
Strabismus. 1996;4(3):127-32. doi: 10.3109/09273979609055047.

The authors report on a newly developed data base program for strabismus patients. All relevant preoperative and postoperative information regarding visual sensory data, motility, squinting angle in nine fields of gaze and head position are easily entered into the...

Cite
Stärk N, Stärk P, Zubcov AA. New data base program for quality control of strabismus surgery. Strabismus. 1996;4(3):127-32doi: 10.3109/09273979609055047.
Stärk, N., Stärk, P., & Zubcov, A. A. (1996). New data base program for quality control of strabismus surgery. Strabismus, 4(3), 127-32. https://doi.org/10.3109/09273979609055047
Stärk, N, et al. "New data base program for quality control of strabismus surgery." Strabismus vol. 4,3 (1996): 127-32. doi: https://doi.org/10.3109/09273979609055047
Stärk N, Stärk P, Zubcov AA. New data base program for quality control of strabismus surgery. Strabismus. 1996;4(3):127-32. doi: 10.3109/09273979609055047. PMID: 21314507.
Copy Download .nbib Format: NLM
Heating Affects Structure, Enterocyte Adsorption and Signalling, As Well as Immunogenicity of the Peanut Allergen Ara h 2.

The open allergy journal

Starkl P, Krishnamurthy D, Szalai K, Felix F, Lukschal A, Oberthuer D, Sampson HA, Swoboda I, Betzel C, Untersmayr E, Jensen-Jarolim E.
PMID: 22318448
Open Allergy J. 2011 Dec 09;4:24-34. doi: 10.2174/1874838401104010024.

Previous studies have indicated that specific molecular properties of proteins may determine their allergenicity. Allergen interaction with epithelia as the first contact site could be decisive for a resulting immune response. We investigate here for the major peanut allergen...

Cite
Starkl P, Krishnamurthy D, Szalai K, et al. Heating Affects Structure, Enterocyte Adsorption and Signalling, As Well as Immunogenicity of the Peanut Allergen Ara h 2. Open Allergy J. 2011;4:24-34doi: 10.2174/1874838401104010024.
Starkl, P., Krishnamurthy, D., Szalai, K., Felix, F., Lukschal, A., Oberthuer, D., Sampson, H. A., Swoboda, I., Betzel, C., Untersmayr, E., & Jensen-Jarolim, E. (2011). Heating Affects Structure, Enterocyte Adsorption and Signalling, As Well as Immunogenicity of the Peanut Allergen Ara h 2. The open allergy journal, 424-34. https://doi.org/10.2174/1874838401104010024
Starkl, Philipp, et al. "Heating Affects Structure, Enterocyte Adsorption and Signalling, As Well as Immunogenicity of the Peanut Allergen Ara h 2." The open allergy journal vol. 4 (2011): 24-34. doi: https://doi.org/10.2174/1874838401104010024
Starkl P, Krishnamurthy D, Szalai K, Felix F, Lukschal A, Oberthuer D, Sampson HA, Swoboda I, Betzel C, Untersmayr E, Jensen-Jarolim E. Heating Affects Structure, Enterocyte Adsorption and Signalling, As Well as Immunogenicity of the Peanut Allergen Ara h 2. Open Allergy J. 2011 Dec 09;4:24-34. doi: 10.2174/1874838401104010024. PMID: 22318448; PMCID: PMC3272452.
Copy Download .nbib Format: NLM
Retraction.

Cancer research

Brauch H, Brenner W, Decker HJ, Hohenfellner R, Huber C, Neuhaus C, Schwerdtle RF, Störkel S, Weidt E, Winterpacht A, Zabel B.
PMID: 10366278
Cancer Res. 1999 Apr 15;59(8):2021.

No abstract available.

Cite
Brauch H, Brenner W, Decker HJ, et al. Retraction. Cancer Res. 1999;59(8):2021
Brauch, H., Brenner, W., Decker, H. J., Hohenfellner, R., Huber, C., Neuhaus, C., Schwerdtle, R. F., Störkel, S., Weidt, E., Winterpacht, A., & Zabel, B. (1999). Retraction. Cancer research, 59(8), 2021.
Brauch, H, et al. "Retraction." Cancer research vol. 59,8 (1999): 2021.
Brauch H, Brenner W, Decker HJ, Hohenfellner R, Huber C, Neuhaus C, Schwerdtle RF, Störkel S, Weidt E, Winterpacht A, Zabel B. Retraction. Cancer Res. 1999 Apr 15;59(8):2021. PMID: 10366278.
Copy Download .nbib Format: NLM
[Günther Schubert : August 17, 1930-October 23, 2017].

Der Pathologe

Störkel S.
PMID: 30203218
Pathologe. 2018 Dec;39:353-354. doi: 10.1007/s00292-018-0490-2.

No abstract available.

Cite
Störkel S. Günther Schubert : 17.08.1930–23.10.2017. [Günther Schubert : August 17, 1930-October 23, 2017]. Pathologe. 2018;39:353-354doi: 10.1007/s00292-018-0490-2.
Störkel, S. (2018). Günther Schubert : 17.08.1930–23.10.2017. [Günther Schubert : August 17, 1930-October 23, 2017]. Der Pathologe, 39353-354. https://doi.org/10.1007/s00292-018-0490-2
Störkel, S. "Günther Schubert : 17.08.1930–23.10.2017." [Günther Schubert : August 17, 1930-October 23, 2017]. Der Pathologe vol. 39 (2018): 353-354. doi: https://doi.org/10.1007/s00292-018-0490-2
Störkel S. Günther Schubert : 17.08.1930–23.10.2017. [Günther Schubert : August 17, 1930-October 23, 2017]. Pathologe. 2018 Dec;39:353-354. doi: 10.1007/s00292-018-0490-2. German. PMID: 30203218.
Copy Download .nbib Format: NLM
Dynamic Changes of the Fungal Microbiome in Alcohol Use Disorder.

Frontiers in physiology

Hartmann P, Lang S, Zeng S, Duan Y, Zhang X, Wang Y, Bondareva M, Kruglov A, Fouts DE, Stärkel P, Schnabl B.
PMID: 34349667
Front Physiol. 2021 Jul 19;12:699253. doi: 10.3389/fphys.2021.699253. eCollection 2021.

BACKGROUND: Alcohol-associated liver disease (ALD) is an important cause of morbidity and mortality worldwide. The intestinal microbiota is involved in the development and progression of ALD; however, little is known about commensal fungi therein.METHODS: We studied the dynamic changes...

Cite
Hartmann P, Lang S, Zeng S, et al. Dynamic Changes of the Fungal Microbiome in Alcohol Use Disorder. Front Physiol. 2021;12:699253doi: 10.3389/fphys.2021.699253.
Hartmann, P., Lang, S., Zeng, S., Duan, Y., Zhang, X., Wang, Y., Bondareva, M., Kruglov, A., Fouts, D. E., Stärkel, P., & Schnabl, B. (2021). Dynamic Changes of the Fungal Microbiome in Alcohol Use Disorder. Frontiers in physiology, 12699253. https://doi.org/10.3389/fphys.2021.699253
Hartmann, Phillipp, et al. "Dynamic Changes of the Fungal Microbiome in Alcohol Use Disorder." Frontiers in physiology vol. 12 (2021): 699253. doi: https://doi.org/10.3389/fphys.2021.699253
Hartmann P, Lang S, Zeng S, Duan Y, Zhang X, Wang Y, Bondareva M, Kruglov A, Fouts DE, Stärkel P, Schnabl B. Dynamic Changes of the Fungal Microbiome in Alcohol Use Disorder. Front Physiol. 2021 Jul 19;12:699253. doi: 10.3389/fphys.2021.699253. eCollection 2021. PMID: 34349667; PMCID: PMC8327211.
Copy Download .nbib Format: NLM
Author Correction: The quest for a unified theory on biomechanical palm risk assessment through theoretical analysis and observation.

Scientific reports

Sterken P.
PMID: 34815509
Sci Rep. 2021 Nov 23;11(1):23072. doi: 10.1038/s41598-021-02407-8.

No abstract available.

Cite
Sterken P. Author Correction: The quest for a unified theory on biomechanical palm risk assessment through theoretical analysis and observation. Sci Rep. 2021;11(1):23072doi: 10.1038/s41598-021-02407-8.
Sterken, P. (2021). Author Correction: The quest for a unified theory on biomechanical palm risk assessment through theoretical analysis and observation. Scientific reports, 11(1), 23072. https://doi.org/10.1038/s41598-021-02407-8
Sterken, Peter. "Author Correction: The quest for a unified theory on biomechanical palm risk assessment through theoretical analysis and observation." Scientific reports vol. 11,1 (2021): 23072. doi: https://doi.org/10.1038/s41598-021-02407-8
Sterken P. Author Correction: The quest for a unified theory on biomechanical palm risk assessment through theoretical analysis and observation. Sci Rep. 2021 Nov 23;11(1):23072. doi: 10.1038/s41598-021-02407-8. PMID: 34815509; PMCID: PMC8610984.
Copy Download .nbib Format: NLM
Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease.

International journal of molecular sciences

Maccioni L, Leclercq IA, Schnabl B, Stärkel P.
PMID: 34884492
Int J Mol Sci. 2021 Nov 24;22(23). doi: 10.3390/ijms222312687.

Chronic alcohol consumption and alcohol-associated liver disease (ALD) represent a major public health problem worldwide. Only a minority of patients with an alcohol-use disorder (AUD) develop severe forms of liver disease (e.g., steatohepatitis and fibrosis) and finally progress to...

Cite
Maccioni L, Leclercq IA, Schnabl B, et al. Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease. Int J Mol Sci. 2021;22(23)doi: 10.3390/ijms222312687.
Maccioni, L., Leclercq, I. A., Schnabl, B., & Stärkel, P. (2021). Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease. International journal of molecular sciences, 22(23), . https://doi.org/10.3390/ijms222312687
Maccioni, Luca, et al. "Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease." International journal of molecular sciences vol. 22,23 (2021). doi: https://doi.org/10.3390/ijms222312687
Maccioni L, Leclercq IA, Schnabl B, Stärkel P. Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease. Int J Mol Sci. 2021 Nov 24;22(23). doi: 10.3390/ijms222312687. PMID: 34884492.
Copy Download .nbib Format: NLM
The menisci and articular cartilage: a life-long fascination.

EFORT open reviews

Kopf S, Sava MP, Stärke C, Becker R.
PMID: 33204508
EFORT Open Rev. 2020 Oct 26;5(10):652-662. doi: 10.1302/2058-5241.5.200016. eCollection 2020 Oct.

The menisci and articular cartilage of the knee have a close embryological, anatomical and functional relationship, which explains why often a pathology of one also affects the other.Traumatic meniscus tears should be repaired, when possible, to protect the articular...

Cite
Kopf S, Sava MP, Stärke C, et al. The menisci and articular cartilage: a life-long fascination. EFORT Open Rev. 2020;5(10):652-662doi: 10.1302/2058-5241.5.200016.
Kopf, S., Sava, M. P., Stärke, C., & Becker, R. (2020). The menisci and articular cartilage: a life-long fascination. EFORT open reviews, 5(10), 652-662. https://doi.org/10.1302/2058-5241.5.200016
Kopf, Sebastian, et al. "The menisci and articular cartilage: a life-long fascination." EFORT open reviews vol. 5,10 (2020): 652-662. doi: https://doi.org/10.1302/2058-5241.5.200016
Kopf S, Sava MP, Stärke C, Becker R. The menisci and articular cartilage: a life-long fascination. EFORT Open Rev. 2020 Oct 26;5(10):652-662. doi: 10.1302/2058-5241.5.200016. eCollection 2020 Oct. PMID: 33204508; PMCID: PMC7608573.
Copy Download .nbib Format: NLM
Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study.

The Lancet. Neurology

Dauvilliers Y, Arnulf I, Foldvary-Schaefer N, Morse AM, Šonka K, Thorpy MJ, Mignot E, Chandler P, Parvataneni R, Black J, Sterkel A, Chen D, Skobieranda F, Bogan RK.
PMID: 34942138
Lancet Neurol. 2022 Jan;21(1):53-65. doi: 10.1016/S1474-4422(21)00368-9.

BACKGROUND: Idiopathic hypersomnia is a central hypersomnolence disorder mainly characterised by excessive daytime sleepiness, with prolonged night-time sleep and pronounced sleep inertia. Until August, 2021, no medication had regulatory approval for the treatment of idiopathic hypersomnia. This study aimed...

Cite
Dauvilliers Y, Arnulf I, Foldvary-Schaefer N, et al. Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study. Lancet Neurol. 2022;21(1):53-65doi: 10.1016/S1474-4422(21)00368-9.
Dauvilliers, Y., Arnulf, I., Foldvary-Schaefer, N., Morse, A. M., Šonka, K., Thorpy, M. J., Mignot, E., Chandler, P., Parvataneni, R., Black, J., Sterkel, A., Chen, D., Skobieranda, F., & Bogan, R. K. (2022). Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study. The Lancet. Neurology, 21(1), 53-65. https://doi.org/10.1016/S1474-4422(21)00368-9
Dauvilliers, Yves, et al. "Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study." The Lancet. Neurology vol. 21,1 (2022): 53-65. doi: https://doi.org/10.1016/S1474-4422(21)00368-9
Dauvilliers Y, Arnulf I, Foldvary-Schaefer N, Morse AM, Šonka K, Thorpy MJ, Mignot E, Chandler P, Parvataneni R, Black J, Sterkel A, Chen D, Skobieranda F, Bogan RK. Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study. Lancet Neurol. 2022 Jan;21(1):53-65. doi: 10.1016/S1474-4422(21)00368-9. PMID: 34942138.
Copy Download .nbib Format: NLM
The gut mycobiome: a novel player in chronic liver diseases.

Journal of gastroenterology

Jiang L, Stärkel P, Fan JG, Fouts DE, Bacher P, Schnabl B.
PMID: 33151407
J Gastroenterol. 2021 Jan;56(1):1-11. doi: 10.1007/s00535-020-01740-5. Epub 2020 Nov 05.

The human gut microbiome (bacteria, fungi, viruses, and archaea) is a complex and diverse ecosystem. It plays an important role in human health, but is involved in several intestinal and extraintestinal diseases. Most research to date has focused on...

Cite
Jiang L, Stärkel P, Fan JG, et al. The gut mycobiome: a novel player in chronic liver diseases. J Gastroenterol. 2020;56(1):1-11doi: 10.1007/s00535-020-01740-5.
Jiang, L., Stärkel, P., Fan, J. G., Fouts, D. E., Bacher, P., & Schnabl, B. (2021). The gut mycobiome: a novel player in chronic liver diseases. Journal of gastroenterology, 56(1), 1-11. https://doi.org/10.1007/s00535-020-01740-5
Jiang, Lu, et al. "The gut mycobiome: a novel player in chronic liver diseases." Journal of gastroenterology vol. 56,1 (2021): 1-11. doi: https://doi.org/10.1007/s00535-020-01740-5
Jiang L, Stärkel P, Fan JG, Fouts DE, Bacher P, Schnabl B. The gut mycobiome: a novel player in chronic liver diseases. J Gastroenterol. 2021 Jan;56(1):1-11. doi: 10.1007/s00535-020-01740-5. Epub 2020 Nov 05. PMID: 33151407; PMCID: PMC7819863.
Copy Download .nbib Format: NLM
The fecal mycobiome in non-alcoholic fatty liver disease.

Journal of hepatology

Demir M, Lang S, Hartmann P, Duan Y, Martin A, Miyamoto Y, Bondareva M, Zhang X, Wang Y, Kasper P, Bang C, Roderburg C, Tacke F, Steffen HM, Goeser T, Kruglov A, Eckmann L, Stärkel P, Fouts DE, Schnabl B.
PMID: 34896404
J Hepatol. 2021 Dec 09; doi: 10.1016/j.jhep.2021.11.029. Epub 2021 Dec 09.

BACKGROUND & AIMS: Studies investigating the gut-liver axis have largely focused on bacteria, whereas little is known about commensal fungi. We characterized fecal fungi in patients with non-alcoholic fatty liver disease (NAFLD) and investigated their role in a fecal...

Cite
Demir M, Lang S, Hartmann P, et al. The fecal mycobiome in non-alcoholic fatty liver disease. J Hepatol. 2021;doi: 10.1016/j.jhep.2021.11.029.
Demir, M., Lang, S., Hartmann, P., Duan, Y., Martin, A., Miyamoto, Y., Bondareva, M., Zhang, X., Wang, Y., Kasper, P., Bang, C., Roderburg, C., Tacke, F., Steffen, H. M., Goeser, T., Kruglov, A., Eckmann, L., Stärkel, P., Fouts, D. E., & Schnabl, B. (2021). The fecal mycobiome in non-alcoholic fatty liver disease. Journal of hepatology, . https://doi.org/10.1016/j.jhep.2021.11.029
Demir, Münevver, et al. "The fecal mycobiome in non-alcoholic fatty liver disease." Journal of hepatology vol. (2021). doi: https://doi.org/10.1016/j.jhep.2021.11.029
Demir M, Lang S, Hartmann P, Duan Y, Martin A, Miyamoto Y, Bondareva M, Zhang X, Wang Y, Kasper P, Bang C, Roderburg C, Tacke F, Steffen HM, Goeser T, Kruglov A, Eckmann L, Stärkel P, Fouts DE, Schnabl B. The fecal mycobiome in non-alcoholic fatty liver disease. J Hepatol. 2021 Dec 09; doi: 10.1016/j.jhep.2021.11.029. Epub 2021 Dec 09. PMID: 34896404.
Copy Download .nbib Format: NLM
Development of a novel, pan-variant aerosol intervention for COVID-19.

bioRxiv : the preprint server for biology

Shoemaker RH, Panettieri RA, Libutti SK, Hochster HS, Watts NR, Wingfield PT, Starkl P, Pimenov L, Gawish R, Hladik A, Knapp S, Boring D, White JM, Lawrence Q, Boone J, Marshall JD, Matthews RL, Cholewa BD, Richig JW, Chen BT, McCormick DL, Gugensberger R, Höller S, Penninger JM, Wirnsberger G.
PMID: 34545364
bioRxiv. 2021 Sep 20; doi: 10.1101/2021.09.14.459961.

To develop a universal strategy to block SARS-CoV-2 cellular entry and infection represents a central aim for effective COVID-19 therapy. The growing impact of emerging variants of concern increases the urgency for development of effective interventions. Since ACE2 is...

Cite
Shoemaker RH, Panettieri RA, Libutti SK, et al. Development of a novel, pan-variant aerosol intervention for COVID-19. bioRxiv. 2021;doi: 10.1101/2021.09.14.459961.
Shoemaker, R. H., Panettieri, R. A., Libutti, S. K., Hochster, H. S., Watts, N. R., Wingfield, P. T., Starkl, P., Pimenov, L., Gawish, R., Hladik, A., Knapp, S., Boring, D., White, J. M., Lawrence, Q., Boone, J., Marshall, J. D., Matthews, R. L., Cholewa, B. D., Richig, J. W., Chen, B. T., McCormick, D. L., Gugensberger, R., Höller, S., Penninger, J. M., & Wirnsberger, G. (2021). Development of a novel, pan-variant aerosol intervention for COVID-19. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2021.09.14.459961
Shoemaker, Robert H, et al. "Development of a novel, pan-variant aerosol intervention for COVID-19." bioRxiv : the preprint server for biology vol. (2021). doi: https://doi.org/10.1101/2021.09.14.459961
Shoemaker RH, Panettieri RA, Libutti SK, Hochster HS, Watts NR, Wingfield PT, Starkl P, Pimenov L, Gawish R, Hladik A, Knapp S, Boring D, White JM, Lawrence Q, Boone J, Marshall JD, Matthews RL, Cholewa BD, Richig JW, Chen BT, McCormick DL, Gugensberger R, Höller S, Penninger JM, Wirnsberger G. Development of a novel, pan-variant aerosol intervention for COVID-19. bioRxiv. 2021 Sep 20; doi: 10.1101/2021.09.14.459961. PMID: 34545364; PMCID: PMC8452093.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 50 entries